Diabetes accelerates steatohepatitis in mice: liver pathology and single-cell gene expression signatures-Reference-Cited by-同舟云学术

Diabetes accelerates steatohepatitis in mice: liver pathology and single-cell gene expression signatures

Published:2024-02 Issue: Volume: Page:
ISSN:0002-9440
Container-title:The American Journal of Pathology
language:en
Short-container-title:The American Journal of Pathology

Author:

Abuduyimiti Tuerdiguli,Goto Hisanori,Kimura Kumi,Oshima Yu,Tanida Ryota,Kamoshita Kyoko,Leerach Nontaphat,Abuduwaili Halimulati,Oo Hein Ko^ORCID,Li Qifang,Galicia-Medina Cynthia M.,Takayama Hiroaki,Ishii Kiyo-aki^ORCID,Nakano Yujiro,Takeshita Yumie,Iba Tomohiro^ORCID,Naito Hisamichi^ORCID,Honda Masao,Harada Kenichi,Yamamoto Yasuhiko^ORCID,Takamura Toshinari^ORCID

Funder

Takeda Science Foundation

Japan Agency for Medical Research and Development

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference34 articles.

1. Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention;Huang;Nat Rev Gastroenterol Hepatol, Nature Publishing Group,2021

2. Histological course of nonalcoholic fatty liver disease in Japanese patients: Tight glycemic control, rather than weight reduction, ameliorates liver fibrosis;Hamaguchi;Diabetes Care,2010

3. Comparison of Tofogliflozin and Glimepiride Effects on Nonalcoholic Fatty Liver Disease in Participants With Type 2 Diabetes: A Randomized, 48-Week, Open-Label, Active-Controlled Trial;Takeshita;Diabetes Care, American Diabetes Association,2022

4. Itoh S, Tsukada Y, Motomura Y, Ichinoe A: Five patients with nonalcoholic diabetic cirrhosis. Acta Hepatogastroenterol (Stuttg) 1979/04/01. 1979, 26:90–97.

5. Ludwig J, Viggiano TR, McGill DB, Ott BJ: Nonalcoholic steatohepatitis. Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980/07/01. 1980, 55:434–438.